Andreas Niedermaier - AlzChem Group CEO Board
| ACT Stock | 57.20 0.40 0.69% |
CEO
Andreas Niedermaier is CEO Board of AlzChem Group AG
| Age | 54 |
| Phone | 49 8621 86 0 |
| Web | https://www.alzchem.com |
AlzChem Group Management Efficiency
The company has return on total asset (ROA) of 0.0508 % which means that it generated a profit of $0.0508 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2651 %, meaning that it generated $0.2651 on every $100 dollars invested by stockholders. AlzChem Group's management efficiency ratios could be used to measure how well AlzChem Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | CEO Age | ||
| Bruce McClelland | Ribbon Communications | 56 | |
| John Stauch | Pentair plc | 58 | |
Management Performance
| Return On Equity | 0.27 | |||
| Return On Asset | 0.0508 |
AlzChem Group AG Leadership Team
Elected by the shareholders, the AlzChem Group's board of directors comprises two types of representatives: AlzChem Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AlzChem. The board's role is to monitor AlzChem Group's management team and ensure that shareholders' interests are well served. AlzChem Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AlzChem Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Manfred Hochreiter, Training Head | ||
| Klaus Englmaier, Member COO | ||
| Georg Weichselbaumer, Chief Board | ||
| HermannJosef Korte, Managing Director | ||
| Andreas Niedermaier, CEO Board | ||
| Michael Hoffmann, Managing Director |
AlzChem Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AlzChem Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.27 | |||
| Return On Asset | 0.0508 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 272.35 M | |||
| Shares Outstanding | 10.14 M | |||
| Shares Owned By Insiders | 52.92 % | |||
| Shares Owned By Institutions | 22.75 % | |||
| Price To Book | 1.26 X | |||
| Price To Sales | 0.31 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for AlzChem Stock Analysis
When running AlzChem Group's price analysis, check to measure AlzChem Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzChem Group is operating at the current time. Most of AlzChem Group's value examination focuses on studying past and present price action to predict the probability of AlzChem Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzChem Group's price. Additionally, you may evaluate how the addition of AlzChem Group to your portfolios can decrease your overall portfolio volatility.